Roux-En-Y Gastric Bypass

Patients who undergo Roux-en-Y gastric bypass may be more sensitive to alcohol exposure compared with those who undergo sleeve gastrectomy and a weight management program, according to a recent study.

In this edition, groups support CMS policy update on colonoscopy; plant-based food intake and CRC research needed; FDA agrees on pediatric study to develop obefazimod and more.

Roux-en-Y gastric bypass was associated with an increased risk for alcohol-use disorder-related hospitalization compared with sleeve gastrectomy and a weight management program, according to research published in JAMA Surgery.

While both Roux-en-Y gastric bypass and sleeve gastrectomy resulted in weight loss and lower HbA1c across all racial and ethnic groups, Black and Hispanic patients who underwent gastric bypass experienced more postsurgical complications.

In this Endo-Sketch, a Healio video series on clinical conditions named after famous colleagues, Klaus Mergener, MD, of the University of Washington School of Medicine, discusses the origin of Roux-en-Y anastomosis.

Roux-en-Y gastric bypass and sleeve gastrectomy are equally effective at reducing hepatic steatosis, with an almost complete clearance of liver fat 1 year after the surgical procedures, according to data from a single-center study.

Adults with obesity who underwent bariatric surgery at a clinic in Turkey had similar improvements in quality of life, regardless whether they underwent a sleeve gastrectomy or Roux-en-Y gastric bypass, according to study data.

Roux-en-Y gastric bypass surgery may be associated with greater weight loss, diabetes control and lower risk for major adverse cardiovascular events compared with sleeve gastrectomy, according to findings published in Diabetes Care.

The number of bariatric surgeries performed in the United States has increased with about 252000 surgeries performed annually.

Bariatric surgery can be an invaluable tool for managing the myriad complications of obesity such as diabetes, fatty liver disease, hypertension, hyperlipidemia, gastroesophageal reflux and obstructive sleep apnea.